🔍 RecallPedia

Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013

Class I - Dangerous
💊 Drugs Recalled: November 13, 2017 Elite Laboratories Prescription Drugs

What Should You Do?

  1. Check if you have this product:
    Lot #: P0910-017, Exp. 05/2019
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Elite Laboratories Inc.
Reason for Recall:
Failed Impurities/Degradation Specifications
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013

Product Codes/Lot Numbers:

Lot #: P0910-017, Exp. 05/2019

Distribution:

Distributed in: NY

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0107-2018